Nanomedicine News RSS Feed - Nanomedicine

Magnetic Nanoparticles Coated with Targeting Proteins Can Stimulate Stem Cells to Regenerate Bone

Magnetic Nanoparticles Coated with Targeting Proteins Can Stimulate Stem Cells to Regenerate Bone

Researchers in bone tissue regeneration believe they have made a significant breakthrough for sufferers of bone trauma, disease or defects such as osteoporosis. [More]
Iron-Oxide Based Nanoparticles Destroy Cancer Cells Using Photo-Thermal Therapy

Iron-Oxide Based Nanoparticles Destroy Cancer Cells Using Photo-Thermal Therapy

Conventional treatment seeks to eradicate cancer cells by drugs and therapy delivered from outside the cell, which may also affect (and potentially harm) nearby normal cells. [More]
New Multiple Drug Eluting Vaginal Ring from Particle Sciences

New Multiple Drug Eluting Vaginal Ring from Particle Sciences

Particle Sciences, Inc (PSI), the leading CDMO for drug eluting devices, has developed and manufactured a new innovative vaginal ring for Ladee Pharma Research Institute (LPRI), the Research and Development arm of Exeltis Pharmaceuticals. [More]
Merrimack Presents Phase 1 Results from Ferumoxytol Iron Oxide Nanoparticle Study at 26th EORTC-NCI-AACR Symposium

Merrimack Presents Phase 1 Results from Ferumoxytol Iron Oxide Nanoparticle Study at 26th EORTC-NCI-AACR Symposium

Merrimack Pharmaceuticals, Inc. today announced data from multiple presentations at the 26th EORTC-NCI-AACR Symposium on Molecular Targets and Therapeutics. Data presented includes the first public presentation on the preclinical activity and potency of MM-131, and preclinical and clinical data on MM-151. [More]
Novavax' Nanoparticle Vaccine for Infant Protection via Maternal Immunization Granted FDA Fast Track Designation

Novavax' Nanoparticle Vaccine for Infant Protection via Maternal Immunization Granted FDA Fast Track Designation

Novavax, Inc., a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation to Novavax' RSV F-Protein nanoparticle vaccine candidate (RSV F vaccine) for protection of infants via maternal immunization. [More]
Nanophosphor Biomarker Lights Up On Detecting Tumour Cells

Nanophosphor Biomarker Lights Up On Detecting Tumour Cells

Nanyang Technological University (NTU) has invented a unique biomarker with two exceptional functions. [More]
Iron-Oxide Nanoparticles Can Successfully Detect Ovarian Tumors In Vivo

Iron-Oxide Nanoparticles Can Successfully Detect Ovarian Tumors In Vivo

Google’s latest search initiative isn’t taking place online, but in the human body instead. On October 28, The Wall Street Journal reported that the Internet giant wants to design tiny magnetic particles to patrol the body for signs of cancer and other diseases. Google said its nanoparticles, less than one-thousandth the width of a red blood cell, would seek out and attach themselves to cells, proteins or other molecules inside the body. [More]
NanoViricides’ Injectable FluCide Drug among ‘Top Ten Infectious Diseases Projects to Watch’

NanoViricides’ Injectable FluCide Drug among ‘Top Ten Infectious Diseases Projects to Watch’

NanoViricides, Inc., announced today that its “Injectable FluCide™” drug candidate for severe influenza has been chosen as one of the “Top Ten Infectious Diseases Projects to Watch” by a panel of industry experts assembled by Informa and the publishers of In Vivo, Startup and The Pink Sheet. [More]
BIND Reports Positive Results from BIND-014 Polymeric Nanoparticle Phase 2 Study in NSCLC

BIND Reports Positive Results from BIND-014 Polymeric Nanoparticle Phase 2 Study in NSCLC

BIND Therapeutics, Inc., a clinical-stage nanomedicine platform company developing targeted and programmable therapeutics called AccurinsTM, today presented positive results from its ongoing Phase 2 study of BIND-014 in non-small cell lung cancer (NSCLC), demonstrating it has met the primary objective in the once every three weeks (Q3W) arm as measured by overall response rate (ORR). [More]
Biodegradable Gelatin Embedded with Nano-Sized Silicate Discs Aids in Blood Coagulation

Biodegradable Gelatin Embedded with Nano-Sized Silicate Discs Aids in Blood Coagulation

Internal bleeding is a leading cause of death on the battlefield, but a new, injectable material developed by team of researchers from Texas A&M University and the Massachusetts Institute of Technology could buy wounded soldiers the time they need to survive by preventing blood loss from serious internal injuries. [More]